Hedda H.
- Country
- Norway
- Department
- Department of Infectious Diseases
Research Overview
Data & Insights
Has run more than one trial at 0 of 10 partner sites.
Specializations
Metabolic Liver Disease
Investigator focuses on non-alcoholic steatohepatitis and its link to metabolic risk factors.
- Fibrosis progression
- Hepatic inflammation pathways
- Insulin‑resistance driven lipogenesis
Therapeutic efforts aim to modify liver injury and metabolic dysregulation.
Cardio‑Renal Co‑Morbidity
Research addresses the intersection of atrial fibrillation and chronic kidney disease stage 5.
- Stroke prevention strategies
- Anticoagulation safety
- Dialysis‑related risk assessment
Emphasis is placed on balancing thrombotic and bleeding risks in this high‑risk population.
Infectious Disease Therapeutics
Investigator contributes to studies on COVID-19, other coronavirus infections, and sepsis.
- Antiviral treatment efficacy
- Host‑directed immunomodulation
- Broad‑spectrum versus narrow‑spectrum antibiotic strategies
Focus lies on reducing disease progression and mortality in acute infections.
Autoimmune Gastrointestinal Disorder
Work includes the management of celiac disease symptoms despite a gluten‑free diet.
- Symptom diary‑guided outcomes
- Mucosal healing assessment
- Targeted enzyme inhibition
Therapeutic aims target persistent intestinal inflammation and symptom control.
Precision Oncology
Investigator is involved in applying precision medicine to advanced cancer with actionable genomic or protein variants.
- Targeted drug matching
- Variant‑driven toxicity profiling
- Clinical implementation pathways
Goal is to improve access to genotype‑guided therapies for patients with refractory malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.